Loading...
Loading...
Contributors:
Dataset URI:
10.5281/zenodo.22922975Background: Cardiovascular involvement is an important complication of childhood-onset systemic lupus erythematosus (cSLE), but clinically overt cardiac manifestations may underestimate the true extent of myocardial involvement. Conventional echocardiography may remain apparently normal despite early impairment of myocardial mechanics. This raises an important clinical question: can cardiac involvement in a child with SLE be detected before the appearance of overt cardiac symptoms?Objective: To critically evaluate the available evidence concerning subclinical cardiac involvement in cSLE and to develop an evidence-based multimodal approach integrating conventional echocardiography, myocardial strain imaging and cardiac biomarkers for earlier detection of myocardial dysfunction.Methods: A structured analytical synthesis of published clinical studies concerning cardiac involvement in cSLE was performed. Particular attention was given to paediatric studies evaluating two-dimensional and three-dimensional speckle-tracking echocardiography, global longitudinal strain (GLS), right ventricular strain, conventional echocardiographic parameters, N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiac troponins. Adult SLE studies were considered selectively when paediatric evidence concerning cardiac biomarkers was limited.Results: Multiple paediatric studies demonstrate that myocardial deformation may be impaired despite preserved left ventricular ejection fraction (LVEF) and absence of clinical heart failure. In a study of 50 asymptomatic children with cSLE, longitudinal and radial myocardial deformation were significantly reduced compared with healthy controls despite conventional measures being less informative. Other paediatric cohorts demonstrated reduced longitudinal strain of the left and right ventricles in clinically asymptomatic patients. More recent three-dimensional speckle-tracking studies have identified subclinical abnormalities of ventricular and atrial myocardial mechanics and suggested prognostic associations. Evidence for cardiac biomarkers is less consistent in children: NT-proBNP was not significantly different between paediatric SLE patients and controls in one prospective study, whereas adult SLE studies demonstrate abnormalities of NT-proBNP and high-sensitivity cardiac troponin even in patients without overt cardiac disease.Conclusion: The available evidence supports the concept that myocardial involvement in cSLE may precede clinically apparent cardiac disease. Conventional echocardiography and LVEF alone may therefore be insufficient for early phenotyping. Myocardial strain, particularly GLS, provides a more sensitive marker of early mechanical dysfunction, while cardiac biomarkers may provide complementary information regarding myocardial stress or injury. A multimodal strategy combining clinical risk assessment, conventional echocardiography, strain imaging and selectively interpreted cardiac biomarkers may improve recognition of early cardiac involvement. Prospective paediatric studies are required to establish age-specific reference values, diagnostic thresholds and clinically validated screening algorithms.
Keyword(s):
childhood-onset systemic lupus erythematosus; cardiac biomarkers; echocardiography; global longitudinal strain; myocardial dysfunction.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)